In vitro efficacy of new β-lactam – β-lactamase inhibitor combinations for Mycobacterium tuberculosis. undefined

Mtb isolates of different lineages were selected to include both wild-type and drug-resistant strains. The aim of the study was to determine the minimum inhibitory concentrations (MICs) for Mtb of meropenem-vaborbactam, meropenem-clavulanic acid, imipenem-relebactam and tebipenem-clavulanic acid.